Enveda
Enveda Biosciences industrializes the discovery of bioactive compounds from the natural world. Its platform combines high-throughput metabolomics with machine learning to decipher the chemical language of nature, identifying therapeutic molecules without the need for slow, traditional fractionation. Enveda translates the planet's chemical diversity into a searchable database for novel drug candidates. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.
Biotechnology
·
Hybrid·
201-500·
$150M Series D
